Floris Groenendaal/LinkedIn
Nov 21, 2025, 08:54
Floris Groenendaal: Periventricular Hemorrhagic Infarction in Term Neonates
Floris Groenendaal, Pediatrician-Neonatologist at University of Utrecht, shared on LinkedIn:
”Our manuscript on term infants with periventricular haemorrhagic infarction has been published.
Our main findings are:
- Seizures around the second day were the most commonly presenting symptom.
- Prothrombotic genetic mutations are potential risk factors in term- born neonates.
- The majority of lesions occurred in the caudate vein territory.
- Most infants showed normal early cognitive outcomes, but motor impairment was significantly more common
So long-term neurodevelopmental follow-up is definitely needed.”
Read the full article here.
Article: Neonates born at term with periventricular haemorrhagic infarction: Risk factors and clinical presentation
Authors: Aleksandra Zaykova, Jeroen Dudink, Floris Groenendaal, Maarten H Lequin, Manon J N L Benders, Maria Luisa Tataranno, Elise Roze
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis